BlackRock, Inc. has informed Sanitec Corporation that its indirect ownership in Sanitec Corporation has decreased below the threshold of 5.0% of the company’s shares and votes as a result of disposal of shares on 14 July 2014. According to the notification, BlackRock Inc. now owns indirectly 4,457,335 shares, equal to approximately 4.46% of Sanitec Corporation’s share capital and total votes. For additional information, please contact: Niklas Alm Head of Investor Relations ir@sanitec.com mob. 46 76 855 7836 Noora Koikkalainen Head of Corporate Communications sanitec.corporation@sanitec.com tel. 358 10 662 5426 About Sanitec – “Home of the Bathroom” Sanitec is the leader in bathroom ceramics in Europe. We have a unique portfolio of some of the most well-known brands with deep roots in the European fixtures markets, strategically positioned to address local markets. We care passionately about people’s needs when it comes to complete bathroom concepts, providing products that stand for guaranteed quality, high level of innovation and attractive design. Stable relationships with key stakeholders in the value chain and our unique brand strengths foster our leading position as well as the loyalty and trust amongst our customers, our network of installers and the end users of our products. Sanitec operates an integrated European group with an unparalleled local presence to provide the best value when it comes to bathroom products. In 2013 net sales amounted to EUR 702 million. Our production network includes 18 production facilities throughout Europe and currently Sanitec employs approximately 6,200 people. Our head office is located in Helsinki, Finland. The shares in Sanitec Corporation are traded on NASDAQ OMX Stockholm under the symbol “SNTC”. For more information about Sanitec, please visit www.sanitec.com.
Notification in accordance with the Finnish Securities
Top 10 Most Recent News Articles
EZaccessMD Data Breach: Class Action Lawsuit Looms
Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...
Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West
Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...
Continue Reading
Uber Data Breach: Class Action Investigation Begins
When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...
Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives
Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...
Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations
ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...
Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries
JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...
Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut
Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...
Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit
A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...
Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control
Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...
Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly
Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...
Continue ReadingTop 5 Most Recently Viewed Articles
Li Auto Inc. Reports Record Revenue and Milestone Deliveries
Li Auto Inc. Announces Impressive Financial Results In the latest quarter, Li Auto Inc. reported a remarkable total revenue of RMB42.9 billion (approximately US$6.1 billion), showcasing a year-over-year growth of 23.6%. This impressive performance reflects the company's strong market presence and strategic execution. Quarterly Deliveries and Growth In terms of vehicle...
Continue Reading
LifeWallet's $2 Million Settlement and Strategic Progress Ahead
LifeWallet's Recent Settlement Progress LifeWallet, formerly known as MSP Recovery, has recently made headlines by announcing a preliminary $2 million settlement as part of its portfolio of pharmaceutical litigation cases. This development is just one part of the company's broader strategy to engage various pharmaceutical and medical device manufacturers. The commitment...
Continue Reading
Revolutionary Approaches to Managing Resistant Hypertension
Understanding Resistant Hypertension Resistant hypertension is a significant challenge for many patients, often referred to as the silent killer due to its insidious nature. Many individuals suffering from high blood pressure are unaware they have it, leading to severe health complications like cardiovascular disease over time. With the upcoming World Hypertension Day,...
Continue Reading
Understanding Wipro's Anticipated Earnings Performance
Understanding Wipro's Anticipated Earnings Performance Wipro (WIT) is poised to release its latest quarterly earnings shortly. Investors are eager to gain insights from this upcoming report, which is shaping up to be a pivotal moment for the company. With analysts estimating an earnings per share (EPS) of $0.07, stakeholders are closely watching for news that could...
Continue Reading
Breakthrough Gene Therapy for Parkinson's Secures FDA Designation
Significant FDA Recognition for AB-1005 AskBio Inc., known for its groundbreaking work in gene therapy, has made headlines with the announcement that its investigational gene therapy AB-1005 has received the esteemed Regenerative Medicine Advanced Therapy (RMAT) designation from the United States Food and Drug Administration (FDA). This acknowledgement comes on the heels...
Continue Reading